Altogether, our observations indicated that the c-Met-HGF-HO-1 pathway plays critical role(s) in counteracting sorafenib-induced ROS generation and apoptosis; it can also be important in regulating chemotherapeutic drug-induced DNA damage repair in RCC cells. Here, HGF is linked to renal cell carcinoma.